PYXUS INTERNATIONAL, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PYXUS INTERNATIONAL, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $643.85M | Jun 7, 2018 |
| FY2018 | Dec 31, 2017 | $477.78M | Jun 7, 2018 |
| FY2018 | Sep 30, 2017 | $447.34M | Jun 7, 2018 |
| FY2018 | Jun 30, 2017 | $276.99M | Jun 7, 2018 |
| FY2018 | Mar 31, 2017 | $609.69M | Jun 7, 2018 |
| FY2018 | Dec 31, 2016 | $454.54M | Jun 7, 2018 |
| FY2018 | Sep 30, 2016 | $389.42M | Jun 7, 2018 |
| FY2018 | Jun 30, 2016 | $261.10M | Jun 7, 2018 |
| FY2017 | Mar 31, 2016 | $732.32M | Jun 14, 2017 |
| FY2017 | Dec 31, 2015 | $491.14M | Jun 14, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $342.98M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $312.34M | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | $261.02M | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | $227.06M | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | $116.47M | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | $45.01M | Jun 14, 2022 |
| FY2020 | Mar 31, 2020 | $69.62M | Aug 24, 2020 |
| FY2020 | Dec 31, 2019 | $55.13M | Aug 24, 2020 |
| FY2020 | Sep 30, 2019 | $60.22M | Aug 24, 2020 |
| FY2020 | Jun 30, 2019 | $39.71M | Aug 24, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $15.17M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $2.66M | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | ($39.14M) | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | ($82.12M) | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | ($136.69M) | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | $19.04M | Jun 14, 2022 |
| FY2020 | Mar 31, 2020 | ($164.35M) | Aug 24, 2020 |
| FY2020 | Dec 31, 2019 | ($21.99M) | Aug 24, 2020 |
| FY2020 | Sep 30, 2019 | ($16.52M) | Aug 24, 2020 |
| FY2020 | Jun 30, 2019 | ($61.80M) | Aug 24, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $153.32M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $137.19M | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | $93.78M | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | $41.72M | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | ($16.05M) | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | ($43.96M) | Jun 14, 2022 |
| FY2022 | Mar 31, 2020 | ($11.61M) | Jun 14, 2022 |
| FY2021 | Mar 31, 2019 | $87.25M | Jun 29, 2021 |
| FY2020 | Mar 31, 2018 | $111.90M | Aug 24, 2020 |
| FY2019 | Mar 31, 2017 | $87.34M | Jun 14, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $171.00M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $160.91M | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | $151.53M | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | $142.02M | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | $110.01M | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | $87.86M | Jun 14, 2022 |
| FY2022 | Mar 31, 2020 | $199.02M | Jun 14, 2022 |
| FY2021 | Mar 31, 2019 | $172.83M | Jun 29, 2021 |
| FY2020 | Mar 31, 2018 | $148.29M | Aug 24, 2020 |
| FY2019 | Mar 31, 2017 | $133.21M | Jun 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($13.39M) | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | ($214.97M) | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | ($137.82M) | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | ($198.77M) | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | ($44.48M) | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | ($182.06M) | Jun 14, 2022 |
| FY2022 | Mar 31, 2020 | ($358.62M) | Jun 14, 2022 |
| FY2021 | Mar 31, 2019 | ($248.28M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2018 | ($307.18M) | Aug 24, 2020 |
| FY2019 | Mar 31, 2017 | $14.20M | Jun 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $23.03M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $21.04M | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | $16.31M | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | $14.83M | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | $16.63M | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | $7.76M | Jun 14, 2022 |
| FY2022 | Mar 31, 2020 | $61.06M | Jun 14, 2022 |
| FY2021 | Mar 31, 2019 | $47.54M | Jun 29, 2021 |
| FY2020 | Mar 31, 2018 | $22.78M | Aug 24, 2020 |
| FY2019 | Mar 31, 2017 | $13.68M | Jun 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.50B | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $1.66B | Jun 10, 2025 |
| FY2024 | Mar 31, 2023 | $1.58B | Jun 6, 2024 |
| FY2023 | Mar 31, 2022 | $1.70B | Jun 6, 2023 |
| FY2022 | Mar 31, 2021 | $1.54B | Jun 14, 2022 |
| FY2022 | Sep 1, 2020 | $1.71B | Jun 14, 2022 |
| FY2022 | Mar 31, 2020 | $1.76B | Jun 14, 2022 |
| FY2021 | Mar 31, 2019 | $1.86B | Jun 29, 2021 |
| FY2020 | Mar 31, 2018 | $1.97B | Aug 24, 2020 |
| FY2019 | Mar 31, 2017 | $1.97B | Jun 14, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.34B | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $1.51B | Jun 10, 2025 |
| FY2024 | Mar 31, 2023 | $1.44B | Jun 6, 2024 |
| FY2023 | Mar 31, 2022 | $1.52B | Jun 6, 2023 |
| FY2022 | Mar 31, 2021 | $1.29B | Jun 14, 2022 |
| FY2022 | Sep 1, 2020 | $1.31B | Jun 14, 2022 |
| FY2021 | Mar 31, 2020 | $1.84B | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $1.67B | Aug 24, 2020 |
| FY2019 | Mar 31, 2018 | $1.68B | Jun 14, 2019 |
| FY2018 | Mar 31, 2017 | $1.77B | Jun 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $160.09M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $142.28M | Jun 10, 2025 |
| FY2024 | Mar 31, 2023 | $137.85M | Jun 6, 2024 |
| FY2023 | Mar 31, 2022 | $175.28M | Jun 6, 2023 |
| FY2022 | Mar 31, 2021 | $247.67M | Jun 14, 2022 |
| FY2021 | Mar 31, 2020 | ($78.00M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $183.71M | Aug 24, 2020 |
| FY2019 | Mar 31, 2018 | $271.87M | Jun 14, 2019 |
| FY2018 | Mar 31, 2017 | $203.52M | Jun 7, 2018 |
| FY2017 | Mar 31, 2016 | $271.13M | Jun 14, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2022 | $0 | Jun 6, 2023 |
| FY2023 | Mar 31, 2021 | $36.85M | Jun 6, 2023 |
| FY2022 | Sep 1, 2020 | $37.94M | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | $0 | Jun 14, 2022 |
| FY2021 | Mar 31, 2020 | $0 | Jun 29, 2021 |
| FY2021 | Mar 31, 2019 | $34.34M | Jun 29, 2021 |
| FY2020 | Mar 31, 2018 | $27.55M | Aug 24, 2020 |
| FY2019 | Mar 31, 2017 | $16.46M | Jun 14, 2019 |
| FY2018 | Mar 31, 2016 | $16.46M | Jun 7, 2018 |
| FY2017 | Mar 31, 2015 | $2.79M | Jun 14, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($240.13M) | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | ($255.29M) | Jun 10, 2025 |
| FY2024 | Mar 31, 2023 | ($257.95M) | Jun 6, 2024 |
| FY2023 | Mar 31, 2022 | ($218.81M) | Jun 6, 2023 |
| FY2022 | Mar 31, 2021 | ($136.69M) | Jun 14, 2022 |
| FY2022 | Sep 1, 2020 | $0 | Jun 14, 2022 |
| FY2021 | Mar 31, 2020 | ($488.55M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($223.88M) | Aug 24, 2020 |
| FY2019 | Mar 31, 2018 | ($156.35M) | Jun 14, 2019 |
| FY2018 | Mar 31, 2017 | ($208.78M) | Jun 7, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2024 | $92.57M | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | $136.73M | Jun 10, 2025 |
| FY2025 | Mar 31, 2022 | $198.78M | Jun 10, 2025 |
| FY2024 | Mar 31, 2021 | $92.71M | Jun 6, 2024 |
| FY2022 | Sep 1, 2020 | $93.14M | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | $93.14M | Jun 14, 2022 |
| FY2022 | Mar 31, 2020 | $170.21M | Jun 14, 2022 |
| FY2022 | Mar 31, 2019 | $192.04M | Jun 14, 2022 |
| FY2021 | Mar 31, 2018 | $264.66M | Jun 29, 2021 |
| FY2020 | Mar 31, 2017 | $473.11M | Aug 24, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $454.86M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | $518.03M | Jun 10, 2025 |
| FY2024 | Mar 31, 2023 | $618.51M | Jun 6, 2024 |
| FY2023 | Mar 31, 2022 | $688.33M | Jun 6, 2023 |
| FY2022 | Mar 31, 2021 | $553.36M | Jun 14, 2022 |
| FY2021 | Mar 31, 2020 | $949.36M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $898.72M | Aug 24, 2020 |
| FY2019 | Mar 31, 2018 | $920.31M | Jun 14, 2019 |
| FY2018 | Mar 31, 2017 | $953.01M | Jun 7, 2018 |
| FY2017 | Mar 31, 2016 | $910.57M | Jun 14, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | (1) | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | (3) | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | (5) | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | 1 | Jun 14, 2022 |
| FY2020 | Mar 31, 2020 | (17) | Aug 24, 2020 |
| FY2020 | Dec 31, 2019 | (2) | Aug 24, 2020 |
| FY2020 | Sep 30, 2019 | (1) | Aug 24, 2020 |
| FY2020 | Jun 30, 2019 | (6) | Aug 24, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jun 10, 2025 |
| FY2025 | Mar 31, 2023 | (1) | Jun 10, 2025 |
| FY2024 | Mar 31, 2022 | (3) | Jun 6, 2024 |
| FY2022 | Mar 31, 2021 | (5) | Jun 14, 2022 |
| FY2022 | Aug 31, 2020 | 1 | Jun 14, 2022 |
| FY2020 | Mar 31, 2020 | (17) | Aug 24, 2020 |
| FY2020 | Dec 31, 2019 | (2) | Aug 24, 2020 |
| FY2020 | Sep 30, 2019 | (1) | Aug 24, 2020 |
| FY2020 | Jun 30, 2019 | (6) | Aug 24, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 24.61M | Jun 10, 2025 |
| FY2025 | Mar 31, 2024 | 25.00M | Jun 10, 2025 |
| FY2024 | Mar 31, 2023 | 25.00M | Jun 6, 2024 |
| FY2022 | Mar 31, 2022 | 25.00M | Jun 14, 2022 |
| FY2022 | Mar 31, 2021 | 25.00M | Jun 14, 2022 |
| FY2021 | Mar 31, 2020 | 9.98M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | 9.88M | Aug 24, 2020 |
| FY2019 | Mar 31, 2018 | 9.81M | Jun 14, 2019 |
| FY2018 | Mar 31, 2017 | 9.75M | Jun 7, 2018 |
| FY2017 | Mar 31, 2016 | 9.69M | Jun 14, 2017 |